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Cell type-specific Nogo-A gene ablation promotes
axonal regeneration in the injured adult optic nerve
F Vajda*,1, N Jordi1, D Dalkara2,3,4, S Joly1, F Christ1, B Tews1,5, ME Schwab1 and V Pernet*,1
Nogo-A is a well-known myelin-enriched inhibitory protein for axonal growth and regeneration in the central nervous system
(CNS). Besides oligodendrocytes, our previous data revealed that Nogo-A is also expressed in subpopulations of neurons
including retinal ganglion cells, in which it can have a positive role in the neuronal growth response after injury, through an
unclear mechanism. In the present study, we analyzed the opposite roles of glial versus neuronal Nogo-A in the injured
visual system. To this aim, we created oligodendrocyte (Cnp-Creþ /xRtn4/Nogo-Aflox/flox) and neuron-specific (Thy1-Cretgþ
xRtn4flox/flox) conditional Nogo-A knock-out (KO) mouse lines. Following complete intraorbital optic nerve crush, both
spontaneous and inflammation-mediated axonal outgrowth was increased in the optic nerves of the glia-specific Nogo-A KO
mice. In contrast, neuron-specific deletion of Nogo-A in a KO mouse line or after acute gene recombination in retinal ganglion
cells mediated by adeno-associated virus serotype 2.Cre virus injection in Rtn4flox/flox animals decreased axon sprouting in the
injured optic nerve. These results therefore show that selective ablation of Nogo-A in oligodendrocytes and myelin in the optic
nerve is more effective at enhancing regrowth of injured axons than what has previously been observed in conventional,
complete Nogo-A KO mice. Our data also suggest that neuronal Nogo-A in retinal ganglion cells could participate in enhancing
axonal sprouting, possibly by cis-interaction with Nogo receptors at the cell membrane that may counteract trans-Nogo-A
signaling. We propose that inactivating Nogo-A in glia while preserving neuronal Nogo-A expression may be a successful
strategy to promote axonal regeneration in the CNS.
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In the adult mammalian central nervous system (CNS), axons
have a very limited capacity to regenerate after traumatic
injury. This lack of axonal regeneration is thought to be mainly
due to the presence of growth-inhibiting molecules in the
injured CNS environment1,2 and due to the low intrinsic growth
capacity of mature neurons.3
Nogo-A is a well-studied inhibitory protein for axonal
growth, plasticity and regeneration after CNS injury.4,5
Nogo-A is predominantly expressed in oligodendrocytes in
the adult CNS, where it is thought to stabilize the neuronal
circuits in healthy conditions and to inhibit neurite growth and
plasticity after lesion.2 Neutralizing Nogo-A by function-
blocking antibodies or genetic knockout (KO) has been shown
to improve axonal sprouting and regeneration in the injured
spinal cord and brain.6–11
In addition to oligodendrocytes and myelin, Nogo-A is
expressed in growing and immature neurons, as well as
in some adult neurons.12,13 Neurons express Nogo-A
receptors such as the Nogo-66 receptor 1 (NgR1)14 and the
Nogo-A-D20-specific sphingosine 1-phosphate receptor 2
(S1PR2).15 They can co-express them along with Nogo-A,13
an observation that raises the possibility of cis-interactions
between the ligand and its receptors within or at the cell
surface of the same cell. This mechanism has previously been
described for axonal guidance molecules such as Ephrins and
Semaphorins, and could have a major role in the neuronal
response to extracellular growth inhibitors during
development.16,17
In the adult CNS, the expression of neuronal Nogo-A
remains elevated mainly in plastic regions such as in the
hippocampus, olfactory bulb or neocortex, and in the dorsal
root ganglia.12 Nogo-A and NgR1 were shown to regulate
synaptic plasticity, for example, long-term potentiation in the
hippocampus and in the sensory-motor cortex,18–22 whereas
the effects of neuronal Nogo-A after injury are not yet well
understood. During development, neuronal Nogo-A influ-
ences neuronal migration,23,24 survival,25,26 cell spreading
and neurite growth.27,28 In injured adult retinal ganglion cells
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(RGCs), silencing neuronal Nogo-A resulted in a marked
reduction of regenerative sprouting and decreased expres-
sion of growth-associated molecules.29 Furthermore, in the
optic nerve, axonal regeneration was not improved in
conventional Nogo-A KO animals, in which both glial and
neuronal Nogo-A were deleted.29 The present study therefore
aimed to investigate whether glial and neuronal Nogo-A
differently influence axonal growth in vivo using cell type-
specific Nogo-A KO mouse lines and adeno-associated virus
(AAV)-mediated recombination of the Nogo-A gene in
neurons. The results show that significantly more axons grew
through the lesion site in the oligodendrocyte-specific Nogo-A
KO mice. In contrast, neuron-specific ablation of Nogo-A in
RGCs reduced the number of regenerating axons after optic
nerve crush injury (ONC). In summary, we show that
inactivating Nogo-A specifically in oligodendrocytes appears
to be the most successful strategy to promote axonal
regeneration in the adult optic nerve.
Results
Targeted deletion of Nogo-A in oligodendrocytes. To
obtain an oligodendrocyte-specific Nogo-A KO mouse line,
mice expressing Cre-recombinase under the control of the
20,30-cyclic nucleotide 30-phosphodiesterase (Cnp-Creþ / )30
were crossed with mice in which exon 3 of the Rtn4 gene was
flanked by loxP sites (Rtn4flox/flox) (Figure 1a). CNPase is a
well-characterized component and marker for myelin and
oligodendrocytes.31 In the optic nerve Olig2-positive oligo-
dendrocytes specifically express CNP (Supplementary
Figure S1A). By performing western blotting in the highly
myelinated optic nerve, the level of Nogo-A protein
decreased by B80% in Cnp-Creþ /xRtn4flox/flox mice
compared with WT, Cnp-Creþ / and Rtn4flox/flox genotypes
(Figure 1b). In the spinal cord, where Nogo-A is expressed in
oligodendrocytes and in neurons, the level of Nogo-A was
decreased by B70% (Figure 1c). In the neocortex of Cnp-
Creþ /xRtn4flox/flox mice, Nogo-A levels were decreased by
B50%, reflecting the higher proportion of neuronal Nogo-A
(Figure 1d).12 In the Cnp-Creþ /xRtn4flox/flox hippocampus,
we observed B30% decrease in Nogo-A (Figure 1e). The
level of the Nogo-A splice variant Nogo-B was elevated in the
optic nerve, spinal cord, cortex and hippocampus, suggest-
ing a compensatory upregulation of this protein in oligoden-
drocytes7 (Figures 1b–e). By immunohistochemistry in the
optic nerve (Figure 1f) and corpus callosum (Figure 1g),
adenomatous polyposis coli (APC)-positive oligodendrocytes
were found to contain Nogo-A in control Cnp-Creþ /
animals, but lacked Nogo-A in Cnp-Creþ /xRtn4flox/flox mice.
Cnp-Cre-driven ablation of Nogo-A increases regenera-
tive axonal sprouting after ONC. The effects of myelin
Nogo-A on the regenerative growth of CNS axons were
assessed in the optic nerve crush model. The retinal ganglion
cell axon growth was analyzed after anterograde tracing with
Alexa594-conjugated cholera toxin B on histological sections
2 weeks after injury. We observed more axonal sprouting
after the lesion site in Cnp-Creþ /xRtn4flox/flox mice than in
the control groups (Figure 2a). Quantitatively, compared with
control genotypes the Cnp-Creþ /xRtn4flox/flox optic nerves
showed more regenerating axons at 50, 100, 150 and 200mm
past the injury site (Figure 2b). The injury-induced growth
response of RGCs was further analyzed by following the gene
expression changes of Sprr1A and growth-associated protein
43 (Gap-43), two known indicators of neuronal growth in the
CNS and the peripheral nervous system.29,32–34 The mRNA
levels of the two growth markers were increased 5 days after
optic nerve crush and were more elevated in the Cnp-Creþ /
xRtn4flox/flox KO retinae than in control samples
(Supplementary Figures S2A and B). These data show that
the targeted deletion of Nogo-A in myelinating cells of the optic
nerve enhances the neuronal growth response after axonal
injury, in marked contrast with our previous analysis in
conventional, systemic Nogo-A KO animals.29
Nogo-A deletion in Cnp-Creþ /xRtn4flox/flox mice
enhances inflammation-induced axonal regeneration
after optic nerve injury. The growth state of RGCs can
be enhanced by intraocular injection of inflammatory agents
such as the Toll-like receptor 2 agonist Zymosan.35,36 In our
study, we observed that the injection of Zymosan at the time
of the injury increased the number of regenerating axons by
B3-fold in all the groups compared with untreated mice. The
enhancement of growing axons was higher in the optic
nerves of Cnp-Creþ /xRtn4flox/flox mice than in WT, Cnp-
Creþ / or Rtn4flox/flox animals (Figures 2c and d). Statisti-
cally more axonal fibers grew across the lesion site in the
Cnp-Creþ /xRtn4flox/flox KO mice at 50, 100, 150, 200 and
300mm past the injury site than in the control genotypes
(Figure 2d). These results show that the combined growth
program stimulation with a pro-inflammatory molecule along
with the deletion of Nogo-A myelin potentiates axonal
regeneration.
Three-dimensional analysis of the growth pattern of
regenerating axons in the transparent optic nerve. The
higher numbers of retinal fibers in Cnp-Creþ /xRtn4flox/flox
optic nerves elongating after the injury site could either be
due to a higher number of individually growing axons or due
to enhanced branching. In order to assess the pattern of
growing axons, a three-dimensional analysis of the regener-
ating fibers was carried out in whole-mounted optic nerves
after tissue clearing using a modified protocol previously
described.37,38 In the optic nerve segments situated between
100 and 300 mm past the lesion site, branched and
unbranched axons could be distinguished, as well as axons
that formed U-turns within this region (Figures 2e and f). We
found that the proportion of branching axons did not
significantly vary between Cnp-Creþ /xRtn4flox/flox and
Rtn4flox/flox control mice (Figure 2g). The percentage of
U-turn-forming axons was not different between the two
genotypes (Figure 2h).
Compensatory upregulation of EphrinA3 and EphA4
in Cnp-Creþ /xRtn4flox/flox mice. We then wondered
whether compensatory mechanisms impede axonal regen-
eration in Cnp-Creþ /xRtn4flox/flox mice after crush lesion.
Our laboratory has previously found that Nogo-A gene deletion
induced the upregulation of inhibitory molecules such as
EphA4 and one of its ligands EphrinA3 in the spinal cord.39
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Figure 1 Generation and characterization of Cnp-Creþ / xRtn4flox/flox Nogo-A KO animals. (a) To obtain an oligodendrocyte-specific Nogo-A KO mouse line, mice
expressing Cre-recombinase under the control of the 20,30-Cnp30 were crossed with mice in which exon 3 of the Rtn4 gene was flanked by loxP sequences (Rtn4flox/flox).
(b–e) Western blot analysis revealed that Nogo-A protein was downregulated in the optic nerve (B80%), spinal cord (B70%), cortex (B50%) and hippocampus (B30%) to
different extents. In all these four examined CNS regions Nogo-B protein showed compensatory upregulation. (f and g) By double immunohistochemistry for Nogo-A and APC
on the optic nerve and corpus callosum sections, Nogo-A was specifically excised from oligodendrocytes in myelinated regions. APC-positive oligodendrocytes contained
Nogo-A only in control animals and lacked Nogo-A in the Cnp-Creþ / xRtn4flox/flox KO mice. Fluorescent pictures were from merged confocal microscopy stacks. Statistics:
one-way ANOVA, Bonferroni’s multiple comparison test, *Po0.05, **Po0.01, ***Po0.001. Scale bars: (f, g)¼ 25mm; insets¼ 5mm
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In EphA4 KO mice, axonal growth was increased in the
injured spinal cord and optic nerve compared with WT
animals.39,40 In the present study, the analysis of EphrinA3
and EphA4 expressions by western blotting revealed a
strong upregulation of EphrinA3 in the optic nerve and an
increase of EphA4 in the retina of Cnp-Creþ xRtn4flox/flox
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compared with Cnp-Creþ / mice (Supplementary Figures
S3A and E). In contrast, myelin-associated glycoprotein
(MAG), a molecule that can block axonal regeneration by
activating the same receptor (NgR1) as Nogo-A,41 did not
change in optic nerves (Supplementary Figure S3B). The
retinal expressions of NgR1 and S1PR2, a newly identified
receptor for Nogo-A,15 were not modified (Supplementary
Figure S5A and Supplementary Figure S3C and F).
These data suggest that EphA4 and EphrinA3 upregula-
tion may restrict the distance of axonal regrowth in
Cnp-Creþ /xRtn4flox/flox optic nerves following injury.
Nogo-A distribution and neuronal survival in the retinae
of Cnp-Creþ /xRtn4flox/flox mice. Western blot analysis
revealed a downregulation of Nogo-A byB85% in glial Nogo-
A KO retinae (Figure 3a), although no oligodendrocytes are
present in this tissue. As in the intact retina of adult mice the
bulk of Nogo-A is expressed by Mu¨ller glial cells,29 we
hypothesized that Nogo-A downregulation may be derived
from expression changes occurring in these cells. In fact,
quantitative real-time polymerase chain reaction (qRT-PCR)
measurements showed a transitory expression of Cnp
mRNA in the postnatal retina (Supplementary Figure S1B).
By immunohistochemistry, the CNP protein was localized in
Mu¨ller cell processes labelled with the specific marker
cellular retinaldehyde binding protein (CRALBP) at P8
(Figure 3e). Nogo-B levels were not changed in Cnp-Creþ /
xRtn4flox/flox retinae (Figure 3a). Compared with the intact,
control mouse retinal flat-mounts, in which Nogo-A appeared
mostly in the end-feet of Mu¨ller cells around bIII-Tubulin-
labelled retinal ganglion cell bodies, Nogo-A expression was
abolished in the Mu¨ller cells of Cnp-Creþ /xRtn4flox/flox KO
retinae (Figure 3b). Strikingly, in the same retinae, Nogo-A
was clearly upregulated in RGCs. Quantitatively, in intact
control retinaeB7% of RGCs expressed Nogo-A, whereas in
the intact Cnp-Creþ /xRtn4flox/flox KOs B55% of RGCs
showed a bright signal for the Nogo-A protein (Figure 3c).
Two weeks after ONC, the proportion of cells expressing
Nogo-A rose to B50% in the surviving retinal ganglion
cell bodies of Rtn4flox/flox control mice, but remained at
B55% in Cnp-Creþ /xRtn4flox/flox animals, a percentage
that did not differ from the intact condition (Figure 3d).
The density of the surviving bIII-Tubulin-positive RGCs was
examined 2 weeks after ONC on retinal flat-mounts
(Figure 3f). The retinal ganglion cell survival was slightly,
but significantly increased in Cnp-Creþ /xRtn4flox/flox
KO animals compared with the control genotypes, from
B25% in Rtn4flox/flox control to B33% in Cnp-Creþ /
xRtn4
flox/flox
KO retinae (Figure 3g).
Nogo-A expression is required in RGCs for optic axon
regeneration. We selectively ablated Nogo-A in RGCs of
Rtn4flox/flox mice by infection with an AAV serotype 2
containing the Cre cDNA (AAV2.Cre). After 4 weeks of
incubation, AAV2.Cre infection reduced the number of Nogo-
A-expressing RGCs in intact Cnp-Creþ /xRtn4flox/flox mice
from B55 to B30% (Supplementary Figures S4A and B).
The injury-induced upregulation of Nogo-A at days 5 and 14
was markedly reduced in retinal ganglion cells transduced
with AAV2.Cre in Rtn4flox/flox animals, from 50% Nogo-A-
positive, surviving cells in WT mice to B15% in the
knockdown retinae at the two time points (Figures 4a–c).
In Cnp-Creþ /xRtn4flox/flox mice, the percentage of Nogo-A-
expressing RGCs decreased from B55% in intact retinae to
B25% at 2 weeks after nerve crush (Figure 4c).
The knockdown of Nogo-A in the RGCs resulted in a
statistically lower number of sprouting fibers at 2 weeks post
injury compared with WT mice injected with AAV2.Cre.
Moreover, AAV2.Cre injection in Cnp-Creþ /xRtn4flox/flox
mice completely prevented the enhancement of regenerative
sprouting that we observed in these animals without the
AAV2.Cre injection (Figure 4d).
To genetically ablate Nogo-A in RGCs, a neuron-specific
Nogo-A KO mouse line was generated by crossing
mice expressing Cre-recombinase under the control of the
Thy1 promoter42 withRtn4flox/flox mice (Figure 5a). By western
blotting in the optic nerve, neuronal KOs showed a
Nogo-A reduction by B40% compared with B80% down-
regulation in glial KOs (Figure 5b). In the primary motor cortex,
Nogo-A was reduced by B40% in glial and by B70% in
neuronal KOs (Figure 5c). As shown before, compared with
the glial Nogo-A KO retinae where Nogo-A expression was
reduced byB90%, we foundB40% reduction of Nogo-A in
the neuron-specific KO retinae (Figure 5d). Importantly,
regenerative axonal sprouting was decreased in neuronal
Nogo-A KO mice after optic nerve injury with respect to
Rtn4flox/flox mice. Quantitatively, the number of axons
growing through the lesion was statistically diminished in
Thy1-CretgþxRtn4flox/flox animals at 50 and 100 mm past the
injury site compared with the control Rtn4flox/flox
group (Figure 5e). Thy1-Cretgþ control mice showed the
same protein expression levels for Nogo-A and Nogo-B in all
Figure 2 Axonal growth is increased after ONC in Cnp-Creþ / xRtn4flox/flox mice. (a) In comparison with WT, Cnp-Creþ / and Rtn4flox/flox control mice, Cnp-Creþ /
xRtn4flox/flox mice showed significantly more growing CTB-594-labelled fibers across the optic nerve lesion site (black stars). (b) The number of growing axonal fibers was
statistically higher in Cnp-Creþ / xRtn4flox/flox, glia-specific Nogo-A KOs (mean±S.E.M., two-way ANOVA, Bonferroni post test, *Po0.05, **Po0.01, ***Po0.001) at 50,
100, 150 and 200mm past the injury site. (c) The intraocular delivery of pro-inflammatory reagent Zymosan at the time of the lesion placed RGCs in an active growth state
resulting in robust axonal growth in the injured optic nerve. (d) In the optic nerves of mice injected with Zymosan, CTB-594-labelled regenerating fibers were dramatically
increased in all genotypes, but were the most abundant in Cnp-Creþ / xRtn4flox/flox animals. Statistically more axons grew across the lesion site in the Cnp-Creþ / xRtn4flox/flox,
glial Nogo-A KO mice (mean±S.E.M., two-way ANOVA, Bonferroni’s post test, *Po0.05, **Po0.01, ***Po0.001) at 50, 100, 150, 200 and 300mm past the injury site than
in control genotypes. (e) Tissue clearing allowed to visualize traced axons in three dimensions in transparent whole-mounted optic nerves 2 weeks after injury (lesion site:
stars). An example of a 3D optic nerve segment is presented for a control Rtn4flox/flox mouse after reconstruction of confocal microscopy image stacks with the Imaris software.
Axons were analyzed at high magnification in the region where Cnp-Creþ /xRtn4flox/flox mice had more sprouting axons, i.e. between 100 and 300mm past the injury site
(two dashed lines). (f) In this range, branched (arrows), un-branched (arrowheads) and U-turn-forming (stars) axons could be identified. (g) The proportion of branching axons
did not significantly vary between Rtn4flox/flox and Cnp-Creþ / xRtn4flox/flox mice. (h) The percentage of U-turn-forming axons was not different between the two genotypes.
Scale bars: (a, c) insets¼ 25mm; (e)¼ 100mm, (f)¼ 50mm
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examined CNS regions and similar axon regeneration
(data not shown) as Rtn4flox/flox animals.
The immunohistochemical signal for the Nogo receptor
NgR1 is increased in Cnp-Creþ /xRtn4flox/flox retinae.
NgR1 is a well-characterized GPI-linked Nogo-A receptor
expressed by intact RGCs in Rtn4flox/flox control and Cnp-
Creþ /xRtn4flox/flox KO mice (Figure 6a). By immunohisto-
chemistry in intact retinal flat-mounts, the level of the NgR1
protein detected in the retinal ganglion cell bodies was found
to be higher in the neurons that expressed a higher level of
Nogo-A compared with cells that showed weak Nogo-A
signal in the Cnp-Creþ /xRtn4flox/flox KO animals (Figures
6b and c). The overall mRNA expression level of NgR1,
however, was not different between the two genotypes in
intact and injured conditions (Supplementary Figure 5A).
The Nogo-A mRNA level reduction was also confirmed with
qRT-PCR experiments (Supplementary Figure 5B). We
hypothesized that the stronger NgR1 signal observed by
immunohistochemistry could reflect the increased associa-
tion of Nogo-A with NgR1 in Nogo-A-positive RGCs. This
close proximity could lead to a cis-interaction between the
ligand and its receptor intracellularly or on the cell membrane
and potentially lead to the attenuation of trans-Nogo-A
signaling (Figures 6f and g). To test this hypothesis, the
activation of the downstream Nogo-A/NgR1 signaling
mediator Rho-A was studied in Rho-A-GTP pull-down
experiments. In the intact conditions where the Rho-A
signaling pathway is not activated, no differences could be
detected in Rho-A-GTP levels between Rtn4flox/flox control
and Cnp-Creþ /xRtn4flox/flox KO retinae. However, after
ONC, significantly less Rho-A-GTP was detected in the
retinae of the Cnp-Creþ /xRtn4flox/flox mice than in samples
collected from control animals (Figures 6d and e). Down-
stream of Rho-A, the level of the inactive, phosphorylated
form of the actin filament severing enzyme Cofilin was
however not changed in Cnp-Creþ /xRtn4flox/flox retinae
(Supplementary Figures S6A–C). None of the regeneration
Figure 3 Retinal ganglion cell body analysis reveals Nogo-A upregulation and higher cell survival in Cnp-Creþ / xRtn4flox/flox KOs. (a) In the retina, Nogo-A expression
was downregulated byB85%, whereas Nogo-B was unchanged in the Cnp-Creþ /xRtn4flox/flox KOs. (b) In intact, Cnp-Creþ / control retinae, Nogo-A was mostly located
in Mu¨ller cell end-feet surrounding bIII-Tubulin-labelled retinal ganglion cell bodies. In contrast, in Cnp-Creþ / xRtn4flox/flox KOs, Nogo-A expression was abolished in Mu¨ller
cells and was strongly upregulated in RGCs. (c) Quantitatively,B7% of RGCs expressed Nogo-A in intact control retinae, whereasB55% of RGCs expressed the Nogo-A
protein in the glial Nogo-A KOs (n¼ 4 per group). (d) Two weeks after ONC injury the density of RGCs expressing Nogo-A was not significantly different between Rtn4flox/flox
and Cnp-Creþ / xRtn4flox/flox mice (n¼ 3 per group). (e) In the retina, the CNP protein was expressed in Mu¨ller cells identified by using the cell-type specific marker CRALBP.
(f) Two weeks after injury, the density of surviving RGCs was evaluated by immunostaining for bIII-Tubulin on retinal flat-mounts. (g) Retinal ganglion cell survival was slightly,
but significantly increased in Cnp-Creþ /xRtn4flox/flox KO animals compared with the control genotypes (n¼ 3–7). Statistics: one-way ANOVA, Bonferroni’s multiple
comparison test, *Po0.05, **Po0.01, ***Po0.001. Scale bars: (b, e, f)¼ 50mm; (b) insets¼ 10mm
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and survival-related signaling pathways such as the
cAMP response element-binding protein (CREB), extracel-
lular-signal-regulated kinase 1/2 (ERK1/2), signal transducer
and activator of transcription 3 (STAT3) and protein
kinase B (AKT) analyzed by western blotting (Supplementary
Figures S6D-M) and immunohistochemistry (Supplementary
Figures S6C, Fand I) showed significant difference between
control and Cnp-Creþ /xRtn4flox/flox retinae.
In vitro, the role of neuronal Nogo-A was tested by plating
dorsal root ganglion (DRG)-derived F11 cells on substrates
coated with increasing concentrations of the Nogo-A inhibitory
fragment Nogo-A-delta20 (D20); Nogo-A inhibited neurite
outgrowth in a concentration-dependent way (Supplementary
Figure S7B). Overexpression of Nogo-A in the F11 cells by
AAV2.Nogo-A attenuated the inhibition of neurite outgrowth
on the Nogo-A-D20 substrate (Supplementary Figures S7A
and B). This result suggests a cell-autonomous effect of
neuronal Nogo-A on neurite outgrowth and supports the
possibility that cis-interaction between Nogo-A and its
receptors may counteract the inhibitory effect of Nogo-A
present in the environment.
Discussion
In the present study we aimed to investigate whether glial and
neuronal Nogo-A differently influence axonal growth in vivo.
We created cell type-specific Nogo-A KO mouse lines and
applied AAV-mediated recombination of the Nogo-A gene in
neurons. Our results show that axonal sprouting is signifi-
cantly increased in the optic nerves of oligodendrocyte-
specific Nogo-A KO mice and accompanied by a decrease
in Rho-A activation in the retina.
Axonal regeneration in conventional versus cell
type-specific Nogo-A KO lines. The characterization of
Cnp-Creþ /xRtn4flox/flox mice (glial Nogo-A KO mice)
revealed oligodendrocyte-specific ablation in myelinated
CNS regions and deletion of Nogo-A from Mu¨ller glial cells
in the retina. In these mice, axonal regeneration was
increased compared with control animals, in line with the
effects obtained by acute pharmacological treatments such
as the anti-Nogo-A antibody infusion, the application of the
soluble NgR1 decoy receptor, or Rho-A/Rho-associated
Figure 4 Neuronal Nogo-A ablation in retinal ganglion neurons reduces axonal sprouting in the injured optic nerve. (a, b) WT and Rtn4flox/flox mice were intraocularly
injected with AAV2.Cre virus 4 weeks before ONC. Five days after crush operation (5dpo), Nogo-A was detected inB50% of RGCs in WT animals. In contrast, the proportion
of injured RGCs expressing Nogo-A was reduced to B15% after transduction with AAV2.Cre virus in Rtn4flox/flox animals. (c) Two weeks after injury B52% of RGCs
expressed Nogo-A in WT control mice, whereas onlyB15% of surviving RGCs contained Nogo-A in AAV2.Cre-injected Rtn4flox/flox mice, andB25% of RGCs were positive
for Nogo-A in AAV2.Cre-injected Cnp-Creþ / xRtn4flox/flox KOs. (d) For the axonal regeneration study, the AAV2.Cre virus was injected 4 weeks before the ONC and
the number of CTB-A594-positive fibers was counted 2 weeks after injury. Quantitatively, compared with WT mice injected with AAV2.Cre, the number of axons growing after
the lesion was statistically lower in the AAV2.Cre-injected Rtn4flox/flox animals. AAV2.Cre injection in the Cnp-Creþ / xRtn4flox/flox prevented axonal regeneration improvement
in glial-Nogo-A KOs (mean±S.E.M., two-way ANOVA, Bonferroni post test, *Po0.05). Scale bar: (a)¼ 50mm
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protein kinase blocking agents.43–45 The improved regenera-
tion that we reported here for the optic nerve is in contrast
with what has previously been observed in systemic,
conventional KO mice.29 We speculate that the lack of
axonal regeneration improvement observed after optic nerve
crush in the conventional, full KO mouse line may be due, at
least in part, to the lack of neuronal Nogo-A expression.29
Nogo-A levels are upregulated after injury in many RGCs,
and the excision of Nogo-A gene by two different experi-
mental approaches, the AAV2.Cre-mediated recombination
and generation of a neuron-specific Nogo-A KO mouse line,
decreased the retinal ganglion cell growth potential and
prevented regeneration improvement in Cnp-Creþ /
xRtn4
flox/flox
KOs. Taken together, our data show that
targeted glial Nogo-A deletion appears to be the most
effective way to stimulate axonal growth in the injured
optic nerve.
The limitations of axonal regeneration by Nogo-A and
guidance molecules in the injured optic nerve. Glial
Nogo-A neutralization potentiated inflammation-induced
axonal regeneration after ONC. The combined treatment
effect emphasizes the importance of making the environment
more permissive to boost regeneration upon intrinsic
growth mechanism activation. The poor intrinsic neuronal
growth can be improved by the deletion of phosphatase and
tensin homolog and suppressor of cytokine signaling 3
(SOCS3), two key players for cell growth inhibition.46
Moreover, inflammation-inducing agents such as Zymosan
or Pam3Cys ((S)-(2,3-bis(palmitoyloxy)-(2RS)-propyl)-Npal-
mitoyl-(R)-Cys-(S)-Ser(S)-Lys(4)-OH.trihydrochloride) have
been shown to increase the intrinsic growth potential of adult
neurons, thereby leading to enhanced regeneration.47,48 Acting
at two levels, the neuronal growth program activation with
Zymosan and the blockade of Nogo-A signaling potentiated
Figure 5 Axonal regeneration is reduced in neuron-specific Nogo-A KO animals. (a) To obtain a neuron-specific Nogo-A KO mouse line, mice expressing
Cre-recombinase under the control of Thy1 promoter42 were crossed with Rtn4flox/flox mouse line. (b–d) Nogo-A and Nogo-B protein expression levels were studied by western
blotting in control (Rtn4flox/flox), glia- (Cnp-Creþ / xRtn4flox/flox) and neuron-specific Nogo-A KO (Thy1-Cretgþ xRtn4flox/flox) mice. (b) In the optic nerve, the downregulation of
Nogo-A was more pronounced in glial (B80%) than in neuronal (B40%) KOs, whereas Nogo-B was similarly upregulated in the two KO mouse lines. (c) In the primary motor
cortex, the downregulation of Nogo-A was less pronounced in glial (B40%) than in neuronal (B70%) KOs. Nogo-B was upregulated in the two KO mouse lines. (d) In the
retina, Nogo-A expression was reduced byB90% in glial and byB40% in the neuron-specific KOs. Contrary to other tissues, the level of Nogo-B was not changed in the
retina of the two conditional KO mouse lines. Statistics: one-way ANOVA, Bonferroni’s Multiple Comparison Test, *Po0.05, **Po0.01, ***Po0.001. (e) The number of
axonal fibers growing spontaneously through the lesion was statistically diminished in neuronal Nogo-A KO, Thy1-Cretgþ xRtn4flox/flox animals at 50, 100 and 200mm past the
injury site when compared with Rtn4flox/flox control groups (mean±S.E.M., Student’s t-test, *Po0.05)
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regenerative growth.49–51 However, our data suggested that
the range of axonal regeneration may be restricted by
compensatory upregulation of EphA4 and EphrinA3 in glial
cells. Further investigation are required to determine (1) how
Nogo-A gene ablation causes Ephrin expression increase,
(2) if additional Ephrins and Semaphorins are upregulated as
well and (3) if this mechanism can be neutralized to potentiate
axonal regeneration in the damaged CNS.
Figure 6 The correlation of Nogo-A and NgR1 expression levels in RGCs suggests a possible cis-interaction. (a) NgR1, Nogo-A and bIII-Tubulin were examined by
immunohistochemistry on retinal flat-mounts in Rtn4flox/flox and Cnp-Creþ /xRtn4flox/flox KO mice. (b) Nogo-A-positive RGCs in the Cnp-Creþ / xRtn4flox/flox mice were
divided into high-(above the mean level of the control mice) and low-expressing cells. (c) The levels of NgR1 correlated with the Nogo-A levels in these two populations of intact
RGCs. (d, e) Rho-A pull-down experiments revealed lower-activated Rho-A-GTP levels in the injured retinae of the Cnp-Creþ / xRtn4flox/flox KO mice. (f) Cartoon showing
trans-activation of the NgR1-S1PR2/Rho-A signaling pathway by oligodendroglial Nogo-A. (g) Hypothetical cis-interaction between Nogo-A and its receptors in neurons, on
the intracellular side, in the endoplasmic reticulum or at the cell membrane, leading to the downstream signaling blockade of Rho-A. Scale bar: (a)¼ 20mm
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Our previous three-dimensional analyses revealed axonal
guidance and patterning defects reflected by increased axonal
U-turns and branching after growth induction in the injured optic
nerve.34,37 In the present study, we hypothesized that the
myelin Nogo-A could have a role in axon guidance after optic
nerve lesion. However, by examining individual growing axons
in 3D, we found no significant difference in the proportion of
branching or U-turn-forming axons between mouse genotypes.
The compensatory enhancement of EphrinA3 in the optic nerve
and EphA4 in the retina that we detected in Cnp-Creþ /
xRtn4
flox/flox
KOs could influence the guidance of regenerating
axons in a complex manner. For example, we reported that
EphA4 KO mice were less prone to form branches in the injured
optic nerve than WT animals.40 In Cnp-Creþ /xRtn4flox/flox
KOs, the lack of guidance and branching changes could result
from the increase of EphA4 or EphrinA3 signaling in regenerat-
ing neurons. In future studies, the impact of compensatory
myelin protein elevations and possibly of that of other repulsive
molecules should be further addressed on axonal guidance in
Cnp-Creþ /xRtn4flox/flox KO mice.52,53
The role of Nogo-A in neuronal survival. We found that
retinal ganglion cell survival was slightly, but significantly
increased in the glial Nogo-A KO animals compared with
control genotypes. Recently, several studies have suggested
that neuronal Nogo-A might have a cell-autonomous role in
improving neuronal survival under conditions of oxidative
stress by scavenging reactive oxygen species,25 inhibiting
oxidative damage26 or recruiting cytoprotective proteins.54
The moderate retinal ganglion cell survival observed in our
study could be related to the neuronal Nogo-A upregulation
in the glial Nogo-A KOs. Moreover, the activation of Rho-A by
myelin Nogo-A could be damaging for neurons after injury;
blocking Rho-A activation after spinal cord injury protected
the cells from p75NTR-dependent apoptosis.55 Similarly, the
increase of retinal ganglion cell survival in Cnp-Creþ /
xRtn4
flox/flox
mice could be due to the reduction of Rho-A
activation that we observed in axotomized retinae.
Nogo-A and Nogo receptors in RGCs: trans- and cis-
interaction? In our study, the increase of the NgR1-
immunohistochemical signal in the highly Nogo-A-positive
RGCs of Cnp-Creþ /xRtn4flox/flox KOs could reflect cis-
interactions between the ligand and receptor. At the cell
membrane, the sequestration and inactivation of ligands by
cis-binding to adjacent receptors has previously been
described to prevent trans-activation in the case of guidance
molecules such as Ephrins,16 semaphorins17 or Slit-Robo,56
but also for the Notch signaling pathway.57 The co-expression
of Nogo-A and NgR1 in RGCs of Cnp-Creþ /xRtn4flox/flox
KO mice could prevent downstream activation of Rho-A after
ONC and Nogo-A overexpression in F11 cells could partially
counteract neurite outgrowth inhibition induced by Nogo-A-D20.
These results suggest a cell-autonomous effect of neuronal
Nogo-A on neurite outgrowth, potentially through cis-interaction
with the Nogo receptors NgR1 or S1PR2.
In summary, the generation of cell type-specific KO mice
allowed to observe that targeted deletion of Nogo-A from glial
cells promotes more neuronal growth in the injured optic nerve
than what has previously been reported in conventional KO
animals. The inactivation of Nogo-A in glia appears as an
optimized strategy to promote axonal regeneration in the CNS.
Materials and Methods
Animals. Rtn4flox/flox mice were generated by TaconicArtemis (Cologne,
Germany). Briefly, the conditional Rtn4 exon 3 allele was generated by
homologous recombination in C57BL/6N ES cells. Exon 3 was flanked by LoxP
sites using a targeting vector with 7.2 kb (long arm) and 3.2 kb (short arm)
homologous sequences, respectively. Correct targeting was verified in ES cells
using southern blotting before performing blastocyst injections. Highly chimeric
male offsprings were bred with C57BL/6 females, transgenic for the presence of a
recombinase gene (Flp-Deleter line). Germline transmission was identified by the
presence of a black coat color, strain C57BL/6. Flp-mediated removal of the FRT
site-flanked positive selection marker gene (PuroR) was verified in the next
generation. Cre-mediated excision of exon 3 resulted in specific loss of function of
the Rtn4 isoform A (Nogo-A), whereas the Rtn4 isoforms B and C (Nogo-B and
Nogo-C) were still expressed. Glia and neuron-specific Nogo-A KO mice were
generated to study the role of glial versus neuronal Nogo-A on axonal
regeneration. Rtn4flox/flox mice were crossed with mice expressing Cre-
recombinase under the control of the 20,30-cyclic nucleotide phosphodiesterase
(Cnp) or Thy1 promoter, respectively. The Cnp-Cre line was generated in the
laboratory of Klaus-Armin Nave.30 The Thy1-Cre line was obtained from the
Jackson Laboratory (Bar Harbor, ME, USA) (FVB/N-Tg(Thy1-cre)1Vln/J) and
back-crossed with C57BL/6 background more than eight times before the breeding
was started with Rtn4flox/flox animals. All procedures and surgeries were performed
on 2–4 month old mice of mixed genders and different genotypes. Animal
experiments were performed in accordance with the guidelines of the Veterinary
Office of the Canton of Zurich.
AAV vector production and application. An AAV2.Cre-mCherry
expressing virus was generated to selectively infect RGCs. AAV vectors were
produced by standard methods. To selectively excise Nogo-A from retinal ganglion
cell neurons in the retina, the AAV2.Cre-mCherry virus was injected to mice with
Rtn4flox/flox genotype. 1.5ml of AAV2.Cre-mCherry virus (1014 vg/ml) was
administered intraocularly using a 10 ml Hamilton syringe adapted with a pulled-
glass tip. To allow the diffusion of the virus, the needle was kept in place for
3–4 min and then carefully removed. Attention was paid not to damage the lens
during the injections. To allow time for optimal transgene expression in vivo, the
injections were performed 4 weeks before the optic nerve crush (ONC) injury.
Axonal regeneration analysis on longitudinal optic nerve
sections. We performed ONC injuries to study axonal regeneration in the
optic nerve and neuronal survival in the retina. The optic nerve was exposed intra-
orbitally and then crushed by tying a knot with a 9-0 suture atB0.5 mm from the
back of the eye. The suture was carefully removed and the integrity of the
ophthalmic artery was examined by fundus examination. To induce intraocular
inflammation, 2ml of 1% Zymosan dissolved in phosphate-buffered saline (PBS)
was injected intraocularly at the time of the injury. Thirteen days after ONC, the
optic axons were anterogradely traced by intraocularly injecting 1.5ml of 0.5%
cholera toxin B conjugated to Alexa594 (CTB-A594, Molecular Probes, Zug,
Switzerland). On the following day, the animals were perfused with 4%
paraformaldehyde (PFA) and the optic nerves were processed as described
below. CTB-A594-positive axons were observed on longitudinal optic nerve
sections (14 mm) with a Zeiss Axioskop 2 Plus microscope (Carl Zeiss, Feldbach,
Switzerland) and images were taken with a CCD video camera at x 20
magnification. The number of growing axons was estimated at different distances
(50, 100, 150, 200, 300, 400, and 500 to 1000 mm) after the lesion site. Five-six
optic nerve sections were analyzed per animal. An estimation of the number of
axons per optic nerve (S) was calculated with the following formula: Sd¼P 
R2  (average number of axons/mm)/T. The sum (S) of axons at a given
distance (d) was obtained using the average optic nerve radius (R) of all optic
nerves at 500 mm past the lesion site, and a thickness (T) of the tissue slices of
14mm. For statistical analysis with multiple comparisons, ANOVA test was applied
followed by a Bonferroni’s post hoc test. Animals with retinal haemorrhages or
ischemia were excluded from the analysis.
Optic nerve preparation and clearing for 3D analysis of
regenerating axons. To visualize CTB-A594-labeled axons in the whole
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injured optic nerve, the tissue was cleared following the adapted protocol from.37
After intracardial perfusion with PBS and 4% PFA, optic nerves were further fixed
overnight, then rinsed with PBS and stored at 4 1C. The samples were dehydrated
in baths of increasing concentrations of tetrahydrofuran (THF, Sigma-Aldrich,
Buchs, Switzerland) (50, 80, and 100%) for 30 min each and for additional 30 min
in 100% THF at room temperature under constant agitation. To remove traces of
water, the optic nerves were placed in dichloromethane for 3–4 h at room
temperature. In the BABB clearing solution (mixture of benzyl alcohol and
benzylbenzoate (1 : 2, Sigma-Aldrich)) the white optic nerve turned transparent
within 30 s. The whole optic nerves were mounted in the clearing medium
before imaging. Image stacks were taken using an inverted confocal Leica SP5
microscope (Leica Microsystems, Mannheim, Germany) equipped with a x63
glycerin immersion objective (NA: 1.3). This setup was used to scan axons
throughout the whole thickness of the optic nerve. To obtain 3D reconstruction
of the optic nerves, image stacks were stitched using the XuvTools42
software58 and the resulting macro-stack was exported to the Imaris Software
(Bitplane, Zurich, Switzerland) to create 3D projections. Individual axons were
analyzed semi-automatically with the Filament Tracers’ advanced manual
tracing mode (‘AutoDepth’). The percentage of U-turns and branching was
calculated between 100 and 300 mm past the lesion site. The best traced 30–60
fibers were selected for growth pattern analysis.
Neuronal survival analysis. Retinal ganglion cell survival was examined 2
weeks after ONC injury. The animals were intracardially perfused with 4% PFA
and the injured and intact retinae were flat-mounted. RGCs were visualized by
immunostaining for bIII-Tubulin (1 : 1000, Promega, Madison, WI, USA), a specific
and reliable marker for labelling all RGCs. The antibodies were diluted in blocking
solution (0.3% Triton-X-100, 5% of normal serum and 0.05% sodium azide in
PBS), and the retinae were incubated at 4 1C with primary and secondary
antibodies, for 5 and 3 days, respectively. The bIII-Tubulin-positive RGCs were
imaged in the four quadrants of the retina using a Leica SPE-II confocal
microscope equipped with a x40 oil immersion objective (NA 1.25). Image stacks
were acquired in the ganglion cell layer with a step size of 0.5mm and a resolution
of 1024 1024 pixels (0.275 mm/pixel). The number of retinal ganglion cell bodies
was quantified in grids of 62500mm2 at 1 and 1.5 mm distances from the optic
disc. The density of surviving RGCs was calculated per mm2.
Retina and optic nerve processing and immunostaining. Mice
were killed by injecting an overdose of anaesthetics intraperitoneally and
perfused intracardially with PBS and 4% PFA. Optic nerves and eyes were
dissected, the latter by removing the cornea and the lens from the eyecup.
For retinal cross sections and longitudinal optic nerve sections, the eye cups
and optic nerves were post-fixed in 4% PFA overnight at 4 1C. The tissues were
then cryoprotected in 30% sucrose and frozen in OCT compound (Tissue-TEK,
Sakura, Torrance, CA, USA) with a 2-methylbutane bath cooled with liquid
nitrogen. Optic nerves and retinal sections were cut (14 mm) with a cryostat.
Immunohistochemical stainings were performed in a blocking solution (5% of
normal goat serum or 5% BSA, 0.3% Triton-X-100 and 0.05% sodium azide in
PBS). Primary antibodies were applied overnight at 4 1C and after PBS washes,
sections were incubated with the appropriate secondary antibody for 1 h at room
temperature. The slides were mounted in Mowiol solution (10% Mowiol 4–88,
Calbiochem, Cambridge, UK, in 100 mM Tris, pH 8.5, 25% glycerol and 0.1%
DABCO). Primary antibodies were: rabbit anti-Nogo-A (Laura, Rb173A40)
serum (1 : 200), mouse anti-glutamine synthetase (1 : 300, Chemicon, Zug,
Switzerland), rabbit anti-CRALBP (1 : 1000, kindly provided by Prof. JC Saari,
Washington), mouse anti-APC (1 : 300, Chemicon), mouse anti-CNP (1 : 300,
Chemicon), goat anti-NgR1 (1 : 50, R&D Systems, Minneapolis, MN, USA),
rabbit anti-phospho-ERK1/2 (1 : 100, Cell Signaling, Danvers, MA, USA), rabbit
anti-phospho-CREB (1 : 100, Cell Signaling), rabbit anti-phospho-Cofilin (1 : 200,
Abcam, Cambridge, UK) and mouse anti-bIII-Tubulin (1 : 1000, Promega).
Immunofluorescent labelling was analyzed with a Zeiss Axioskop 2 Plus
microscope or with Leica SPE-II confocal microscope.
Western blot analysis. After cervical dislocation, retinae and optic nerves
were quickly dissected out and flash frozen in liquid nitrogen. Tissues were kept at
 80 1C until extraction in lysis buffer (RIPA buffer: 150 mM NaCl, 1% NP40,
0,5% deoxycholate, 0.1% SDS in 50 mM Tris buffer at pH 8) containing protease
inhibitors (Complete mini, Roche Diagnostics, Indianapolis, IN, USA). Samples
were fully homogenized and let on ice for 60 min. After centrifugation for 15 min at
15 000 g, 4 1C, supernatants were collected and processed for protein
concentration analysis (Bio-Rad Laboratories, Richmond, CA, USA, RC DC
Protein Assay). Retinal and optic nerve proteins (20 mg/lane) were separated by
electrophoresis on a 4–12% polyacrylamide gel and transferred to nitrocellulose
membranes. Blots were incubated in a blocking solution of either 2% Top Block
(Lubio Science, Luzern, Switzerland) or 5% BSA (bovine serum albumin) in 0.2%
TBST (0.2% Tween-20 in Tris-base 0.1 M, pH 7.4) for 1 h at room temperature,
then incubated with primary antibodies overnight at 4 1C. Following the washing
steps, membranes were incubated with horseradish peroxidase-conjugated anti-
mouse or anti-rabbit secondary antibodies (1 : 10 000–1 : 25 000; Pierce Biotech-
nology, Rockford, IL, USA). Primary antibodies were rabbit anti-Nogo-A/B (Bianca,
Rb140) serum (1 : 20 000), mouse anti-L-MAG serum (1 : 1 000, polyclonal),59
mouse anti-EphA4 (1 : 200, Invitrogen, Zug, Switzerland), rabbit anti-EphrinA3
(1 : 200, Invitrogen), mouse anti-S1PR2 (1 : 500, Santa Cruz Biotechnology, Santa
Cruz, CA, USA), rabbit anti-phospho-STAT3 (1 : 500, Cell Signaling), rabbit
anti-STAT3 (1 : 500, Cell Signaling), rabbit anti-phospho-ERK1/2 (1 : 1000, Cell
Signaling), rabbit anti-ERK1/2 (1 : 1000, Cell Signaling), rabbit anti-phospho-AKT
(1 : 500, Cell Signaling), rabbit anti-AKT (1 : 500, Cell Signaling), rabbit
anti-phospho-CREB (1 : 500, Cell Signaling), rabbit anti-CREB (1 : 500, Cell
Signaling), rabbit anti-phospho-Cofilin (1 : 500, Abcam), rabbit anti-Cofilin (1 : 500,
Cell Signaling), and mouse anti-glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (1 : 20 000; Abcam). Protein bands were detected with SuperSignal
West Pico Chemiluminescent Substrate (Pierce Biotechnology) in a Stella detector
(Raytest, Straubenhardt, Germany). Band intensities were measured with the
Image J software (NIH).
Rho-A pull-down. After rapid dissection of intact and injured (3 days post
operation) retinae in TBS, the samples were flash frozen in liquid nitrogen and
stored at  80 1C until performing the Rho-A pull-down. The pull-down of
activated RhoA-GTP was subsequently performed using the RhoA Activation
Assay Biochem Kit according to the manufacturer’s instructions (Cytoskeleton,
Inc., Denver, CO, USA) combined with a previously described protocol.60 The
Rho-A-GTP pull-down and total lysate samples were then subjected to
electrophoresis on a 4–12% polyacrylamide gel and transferred to nitrocellulose
membranes. After blocking with 5% BSA in 0.2% TBST for 1 h, the membranes
were incubated overnight at 4 1C with a rabbit anti-Rho-A (1 : 400, Cell Signaling)
primary antibody. The secondary antibody incubation and signal detection was
performed as described before for the western blots.
Semi-quantitative RT-PCR (qRT-PCR). After cervical dislocation, intact
and injured whole retinae were rapidly dissected in PBS. The samples were flash
frozen in liquid nitrogen and stored at  80 1C until RNA extraction. The retinal
RNA was prepared using the RNeasy RNA isolation kit (Qiagen, Hombrechtikon,
Switzerland), including a DNase treatment to digest the residual genomic DNA.
For reverse transcription, equal amounts of total RNA were transformed to cDNA
by using oligo(dT) primers and M-MLV reverse transcriptase (Promega). 10 ng of
cDNA was amplified in the Light Cycler 480 thermocycler (Roche Diagnostics AG)
with the polymerase ready mix (SYBR Green I Master; Roche Diagnostics). The
following specific primers were designed to span intronic sequences or cover
exon–intron boundaries: Gapdh (forward, 50-CAGCAATGCATCCTGCACC-30;
reverse, 50-TGGACTGTGGTCATGAGCCC-30), Cnp (forward, 50-AGGAGAAG
CTTGAGCTGGTC-30; reverse, 50-CGATCTCTTCACCACCTCCT-30), Nogo-A/
Rtn4 (forward, 50-CAGTGGATGAGACCCTTTTTG-30; reverse, 50-GCTGCTC
CTTCAAATCCATAA-30), NgR1/Rtn4R (forward, 50-CTCGACCCCGAAGAT
GAAG-30; reverse: 50-TGTAGCACACACAAGCACCAG-30), Gap-43 (forward, 50-T
GCTGTCACTGATGCTGCT-30; reverse, 50-GGCTTCGTCTACAGCGTCTT-30),
small proline-rich protein 1A (Sprr1A, forward, 50-GAACCTGCTCTTCTCTGAGT-
30; reverse, 50-AGCTGAGGAGGTACAGTG-30). For relative quantification of gene
expression, mRNA levels were normalized to GAPDH using the comparative
threshold cycle (DDCT) method and a control sample was used to calculate the
relative values. Each reaction was done in triplicate and 3–4 mice per condition
were analyzed.
Cell cultures. The effects of AAV2.green fluorescent protein (GFP) and
AAV2.Nogo-A on neurite outgrowth were evaluated in vitro by infecting F11 cells.
The F11 cell line, kindly provided by Prof. RE van Kesteren (Amsterdam, The
Netherlands), was maintained as described before.61 F11 cells were plated at a
density of 100 000 cells per well in six-well plates and were treated with
AAV2.GFP or AAV2.Nogo-A viruses 24 h later. After a period of 4 days after
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infection, F11 cells were transferred to 4-well dishes at a density of 2000 cells per
well. The four-well dishes were coated by different concentrations of Nogo-A-D20
substrate (0, 0.5, 1 and 2.5mg/cm2) diluted in PBS at 4 1C for 12 h. Twenty
four hours after plating the cells on Nogo-A-D20 substrate, F11 cells
were differentiated by adding 10 mM of Forskolin (Sigma-Aldrich) for 48 h.
To visualize neurite extension, F11 cells were stained with bIII-Tubulin antibody.
Measurement of neurite length was carried out using the Neuron J plugin in the
Image J software (NIH). The mean of the total neurite length was calculated for the
AAV2.GFP and AAV2.Nogo-A treatments on all four Nogo-A-D20 substrate
concentrations measuring between 80 and 110 cells.
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